Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis

American Journal of Medicine

Volumn 118, Issue 7 SUPPL., 2005, Pages 39-44

  Martinez, Fernando J ^a   Anzueto, Antonio ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute exacerbations of chronic bronchitis; Antibiotics; Chronic obstructive pulmonary disease; Fluoroquinolones; Resistance; Short coursetherapy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ARTICLE; CHRONIC BRONCHITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DRUG CHOICE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; GLUCOSE HOMEOSTASIS; HUMAN; MEDICAL SOCIETY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT PROLONGATION; RISK ASSESSMENT; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 21744454322     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.05.012     Document Type: Article

References (42)

1. B.R. Celli, W. MacNee Standards for the diagnosis and treatment of patients with COPD a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
2. S. Sethi Infectious etiology of acute exacerbations of chronic bronchitis Chest 117 suppl 2 2000 380S 385S
3. R.F. Grossman Guidelines for the treatment of acute exacerbations of chronic bronchitis Chest 112 suppl 1997 310S 313S
4. K.R. Flaherty, S. Saint, A.M. Fendrick, F.J. Martinez The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy Postgrad Med 109 2001 39 47
5. M.S. Niederman, J.S. McCombs, A.N. Unger, A. Kumar, R. Popovian Treatment cost of acute exacerbations of chronic bronchitis Clin Ther 21 1999 576 591
6. S. Saint, K.R. Flaherty, P. Abrahamse, F.J. Martinez, A.M. Fendrick Acute exacerbation of chronic bronchitis disease-specific issues that influence the cost-effectiveness of antimicrobial therapy Clin Ther 23 2001 499 512
7. R. Rodriguez-Roisin Toward a consensus definition for COPD exacerbations Chest 117 2000 398S 401S
8. P. Ball Acute infective exacerbations of chronic bronchitis Q J Med 88 1995 61 68
9. M.S. Balter, J. La Forge, D.E. Low, L. Mandell, R.F. Grossman Canadian guidelines for the management of acute exacerbations of chronic bronchitis Can Respir J 10 suppl B 2003 3B 32B
10. A. Anzueto, M.S. Niederman Diagnosis and treatment of rhinovirus respiratory infections Chest 123 2003 1664 1672
11. W.C. Tan, X. Xiang, D. Qiu, T.P. Ng, S.F. Lam, R.G. Hegele Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease Am J Med 115 2003 272 277
12. V. Bandi, M. Jakubowycz, C. Kinyon Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae FEMS Immunol Med Microbiol 37 2003 69 75
13. G. Rohde, A. Wiethege, I. Borg Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation a case-control study Thorax 58 2003 37 42
14. S.G. Adams, A. Anzueto Antibiotic therapy in acute exacerbations of chronic bronchitis Semin Respir Infect 15 2000 234 247
15. N.R. Anthonisen, J. Manfreda, C.P.W. Warren, E.S. Hershfield, G.K.M. Harding, N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204
16. F.J. Martinez Acute exacerbations of chronic bronchitis diagnosis and therapy J Clin Outcomes Manage 11 2004 659 673
17. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease results from the lung health study Am J Respir Crit Care Med 164 2001 358 364
18. G.C. Donaldson, T.A. Seemungal, A. Bhowmik, J.A. Wedzicha Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease Thorax 57 2002 847 852
19. R. Wilson, L. Allegra, G. Huchon Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis Chest 125 2004 953 964
20. H. Lode, J. Eller, A. Linnhoff, M. Ioanas Levofloxacin versus clarithromycin in COPD exacerbation focus on exacerbation-free interval Eur Respir J 24 2004 947 953
21. R. Wilson, J.J. Schentag, P. Ball, L. Mandell A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes Clin Ther 24 2002 639 652
22. M. Miravitlles Grupo de Trabajo de la Asociacion Latinoamericana del Torax (ALAT) Update to the Latin American Thoracic Association (ALAT) Recommendations on Infectious Exacerbation of Chronic Obstructive Pulmonary Disease [in Spanish] Arch Bronconeumol 40 2004 315 325
23. L.G. Reimer, K.C. Carroll Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections Clin Infect Dis 26 1998 742 748
24. S. Sethi, T.F. Murphy Acute exacerbations of chronic bronchitis new developments concerning microbiology and pathophysiology - impact on approaches to risk stratification and therapy Infect Dis Clin North Am 18 2004 861 882, ix
25. S. Brunton, B.P. Carmichael, R. Colgan Acute exacerbation of chronic bronchitis a primary care consensus guideline Am J Manag Care 10 2004 689 696
26. M.S. Balter, J. La Forge, D.E. Low, L. Mandell, R.F. Grossman Canadian guidelines for the management of acute exacerbations of chronic bronchitis executive summary Can Respir J 10 2003 248 258
27. O.G. Vanderkooi, D.E. Low, K. Green, J.E. Powis, A. McGeer Toronto Invasive Bacterial Disease Network Predicting antimicrobial resistance in invasive pneumococcal infections Clin Infect Dis 40 2005 1288 1297
28. T.B. Giblin, R.L. Sinkowitz-Cochran, P.L. Harris CDC Campaign to Prevent Antimicrobial Resistance Team Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities Arch Intern Med 164 2004 1662 1668
29. M.A. Pfaller, A.F. Ehrhardt, R.N. Jones Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study microbiology from the medical office practice environment Am J Med 111 2001 4S 12S
30. Data on file. Proceedings of the TRUST 7 (2002-2003) Surveillance Study 2003 Ortho-McNeil Pharmaceutical, Inc Raritan, NJ
31. J. Segreti, H. House, R. Siegel Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting Am J Med 118 suppl 7A 2005 21S 28S
32. J. Nazir, C. Urban, N. Mariano Quinolone-resistant Haemophilus influenzae in a long-term care facility clinical and molecular epidemiology Clin Infect Dis 38 2004 1564 1569
33. R.F. Grossman, J.C. Rotschafer, J. Tan Antimicrobial treatment of lower respiratory tract infections in the hospital setting Am J Med 118 suppl 7A 2005 29S 38S
34. T.M. File Jr Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia Clin Infect Dis 39 suppl 3 2004 S159 S164
35. T.M. File Jr A new dosing paradigm high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia Clin Cornerstone Suppl 3 2003 S21 S28
36. M.H. Gotfried, L.H. Danziger, K.A. Rodvold Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects Chest 119 2001 1114 1122
37. P.D. Lister Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae Diagn Microbiol Infect Dis 44 2002 43 49
38. P.D. Lister, CC. Sanders Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae J Antimicrob Chemother 43 1999 79 86
39. P.D. Lister Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model impact of area under the curve/MIC ratios on eradication Antimicrob Agents Chemother 46 2002 69 74
40. J.C. Pechere, L. Lacey Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis J Antimicrob Chemother 45 2000 19 24
41. R. Grossman, J. Mukherjee, D. Vaughan Canadian Ciprofloxacin Health Economic Study Group A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis Chest 113 1998 131 141
42. M. Miravitlles, C. Murio, T. Guerrero, R. Gisbert Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD Chest 121 2002 1449 1455